Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Subcutaneous glucagon may be better than oral glucose for prehospital treatment of symptomatic hypoglycemia.

Subcutaneous glucagon may be better than oral glucose for prehospital treatment of symptomatic hypoglycemia. Diabetes Care. 2003 Aug; 26(8):2472-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.